Echosens North America Inc is a pioneering company in the field of liver diagnosis, offering FibroScan as a non-invasive gold standard solution for comprehensive management of liver health. With over 4,200 peer-reviewed publications and 180 international guidelines, FibroScan is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment. Echosens has made FibroScan available in over 100 countries, enabling millions of liver examinations globally.
Echosens' liver health solutions include the FibroScan Family, which provides a comprehensive assessment of liver disease, and the Scores solutions, which enhance FibroScan capabilities for improved management of fatty liver patients. Their commitment to early detection and monitoring of liver diseases aims to reverse the effects and improve the well-being of individuals. With a focus on innovation and clinical evidence, Echosens continues to be at the forefront of liver health diagnostics.
Generated from the website